Standout Papers

Fezolinetant for treatment of moderate-... 2018 2026 2020 2023 443
  1. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study (2023)
    Samuel Lederman, Antonio Cano et al. The Lancet
  2. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT (2023)
    Nancy Martin, Rossella E. Nappi et al. The Journal of Clinical Endocrinology & Metabolism
  3. Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade (2018)
    Masha G. Savelieff, Geewoo Nam et al. Chemical Reviews

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 22

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
5 intermediate papers

Works of Misun Lee being referenced

Engineering Thermostability in Artificial Metalloenzymes to Increase Catalytic Activity
2021
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
2018 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Misun Lee 103 333 424 317 58 1.8k
Xiaolei Ma 199 1187 251 480 77 2.8k
Rita Santamaria 124 801 162 197 72 2.3k
Rudolf Flückiger 325 1225 89 404 61 3.0k
Fernanda Bueno Morrone 115 662 138 178 96 2.4k
Erika Di Zazzo 185 1298 200 129 42 2.8k
Simona Ceccarelli 210 954 109 136 86 2.5k
Victor A. Najjar 289 1042 139 265 69 2.3k
Wan Lee 352 1500 332 448 113 2.6k
Kazuyoshi Ikeda 66 801 101 458 64 2.2k
Há Thi Nguyen 203 650 102 187 67 2.0k

All Works

Loading papers...

Rankless by CCL
2026